180 Life Sciences EV/EBIT
Was ist das EV/EBIT von 180 Life Sciences?
EV/EBIT von 180 Life Sciences Corp. ist N/A
Was ist die Definition von EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu 180 Life Sciences
Was macht 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Unternehmen mit ev/ebit ähnlich 180 Life Sciences
- Asensus Surgical Inc hat EV/EBIT von N/A
- Aurelius Minerals hat EV/EBIT von N/A
- Pintec Technology Ltd hat EV/EBIT von N/A
- Spherix hat EV/EBIT von N/A
- DiscovEx Resources hat EV/EBIT von N/A
- Superconductor Technologies hat EV/EBIT von N/A
- 180 Life Sciences hat EV/EBIT von N/A
- Westar Resources hat EV/EBIT von N/A
- Chaparral hat EV/EBIT von N/A
- Katoro Gold plc hat EV/EBIT von N/A
- Synairgen plc hat EV/EBIT von N/A
- Graycliff Exploration hat EV/EBIT von N/A
- DBV Technologies hat EV/EBIT von N/A